James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Secondary Offerings: Friend or Foe?

There are reasons to like (and dislike) a secondary offering ... but they usually have little to do with the offering itself.

The Market Says Obamacare Is Here to Stay

The relative performance of the healthcare sector's industries says investors expect Obamacare to survive the debt-ceiling battle.

3 Warnings Before You Play With Inverse ETFs Like DUST

What's the best way to use, or best reason to avoid, a bearish leveraged gold fund like the Direxion Daily Gold Miners Bear 3X Shares (DUST)? That depends.

Roche’s Breast Cancer Drug Approval Is Just the Beginning

It might have been dismissed as irrelevant by most investors, but Roche and its Perjeta could reshape the breast cancer drug landscape.

3 Stocks That Don’t Care About a Government Shutdown

In the unlikely event a government shutdown is allowed to materialize for any length of time, these three investment types should hold up despite the freeze.